- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Basilea Pharmaceutica+ Add to Watchlist
PK5:GR80.643 EUR 1.050 1.29%
As of 03:08:34 ET on 08/01/2014.
Company Profile for Basilea Pharmaceutica (PK5)
Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.
Key Executives for Basilea Pharmaceutica (PK5)
|Domenico ScalaVice Chairman||Ronald Scott "Ron"Chief Executive Officer|
|Donato SpotaChief Financial Officer||Ingrid Heinze-KraussChief Technology Officer|
|Achim KaufholdChief Medical Officer||Laurenz KellenbergerChief Scientific Officer|
|Barbara ZinkHead:Corporate Development||Heidi McDaidHead:Global Human Resources|